Developing new drugs is complex, costly and slow – a challenge only exacerbated as the industry moves towards more innovative drug formats. R&D leaders must balance the need to discover novel modalities with the need to develop new methods and strategies that will make the process as fast and efficient as possible.

This is at the core of Discovery & Development. We empower scientific leaders from the world’s most innovative biopharma and research organisations to make informed pipeline decisions in early R&D, accelerating their route from target identification to novel clinical candidate.